Health minister Greg Hunt says the government will work with the sector to "ensure" Australian patients access gene and cell therapies as Alnylam Pharmaceuticals, the company with the first approved RNA interference therapeutic, confirms it has no current plan to bring ONPATTRO to Australia. …
Greg Hunt: Will work to 'ensure' patient access to gene and cell therapies
June 21, 2019 Latest NewsNews of the Day
Latest Video
New Stories
-
La Trobe launches REACH program to fight antimicrobial resistance
May 6, 2026 - - Latest News -
If the imperative is international comparison, why limit it to these definitions?
May 5, 2026 - - Latest News -
Therapy funded three years after the 'clunky' and 'preventable deaths' admission
May 5, 2026 - - Latest News -
Time to make this 'targeted' consultation a little less targeted
May 5, 2026 - - Latest News -
Australia approves first in class therapy for chronic graft versus host disease
May 5, 2026 - - Latest News -
Lilly therapy approved in Australia as first non-covalent BTK inhibitor for common blood cancer
May 5, 2026 - - Latest News -
Medicines Australia calls for transparency, highlighting the risk of bias
May 5, 2026 - - Latest News